Innoviva (INVA) Operating Expenses (2010 - 2026)

Innoviva's Operating Expenses history runs 17 years deep, the most recent figure standing at $37.7 million for Q1 2026.

• Quarterly Operating Expenses rose 18.16% year-over-year to $37.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $179.3 million (up 14.55% YoY) and the FY2025 annual result came in at $143.9 million, up 11.27% from the prior year.
• Operating Expenses was $37.7 million for Q1 2026 at Innoviva, down from $107.2 million in the prior quarter.
• Across five years, Operating Expenses topped out at $107.2 million in Q3 2025 and bottomed at -$219.2 million in Q3 2022.
• A 5-year average of $37.4 million and a median of $37.7 million in 2026 frame the typical range for Operating Expenses.
• Peak annual rise in Operating Expenses reached 1956.38% in 2022, while the deepest fall reached 109.53% in 2022.
• Innoviva's Operating Expenses stood at -$219.2 million in 2022, then soared by 141.85% to $91.7 million in 2023, then increased by 2.86% to $94.4 million in 2024, then rose by 13.66% to $107.2 million in 2025, then plunged by 64.87% to $37.7 million in 2026.
• Business Quant data shows INVA's Operating Expenses at $37.7 million in Q1 2026, $107.2 million in Q3 2025, and $34.4 million in Q2 2025.